scispace - formally typeset
Search or ask a question

Blood-brain barrier and ephytelial intestinal barrier dysfunction: ¿does it is a common point in psychiatric disorders? 


Best insight from top research papers

The blood-brain barrier (BBB) is a crucial component of the central nervous system (CNS) that regulates the passage of substances and immune cells between the blood and the brain . BBB disruption has been associated with the onset and progression of major neurological disorders . Major depression, a prevalent psychological disease, has also been linked to BBB disruption, which contributes to increased susceptibility to depression . The BBB is a specialized multicellular structure that requires coordinated interactions between various CNS cell types and structures, known as the neurovascular unit (NVU) . BBB dysfunction has been observed in several disease states, including schizophrenia, epilepsy, traumatic brain injury, autism, and DiGeorge syndrome . Methamphetamine abuse can cause structural or functional abnormalities of the BBB, increasing the risk of neurodegenerative diseases . While the relationship between blood-brain barrier and epithelial intestinal barrier dysfunction in psychiatric disorders is not explicitly addressed in the provided abstracts, the role of BBB dysfunction in psychiatric disorders is highlighted.

Answers from top 5 papers

More filters
Papers (5)Insight
Open accessJournal ArticleDOI
Lu Pang, Yun Xiu Wang 
01 May 2023
The provided paper does not discuss the relationship between blood-brain barrier dysfunction and psychiatric disorders.
The provided paper discusses the blood-brain barrier dysfunction in several disease states, including schizophrenia. However, it does not mention anything about the dysfunction of the epithelial intestinal barrier or its association with psychiatric disorders.
The provided paper does not discuss the relationship between blood-brain barrier dysfunction and psychiatric disorders.
The provided paper does not discuss the relationship between blood-brain barrier dysfunction and psychiatric disorders. The paper focuses on the structure and function of the blood-brain barrier in both healthy and altered/diseased conditions, as well as potential therapeutic targets for restoring its integrity in brain disorders.
The provided paper does not discuss the relationship between blood-brain barrier dysfunction and epithelial intestinal barrier dysfunction in psychiatric disorders.

Related Questions

What gastrointestinal diseases are present in ASD?5 answersGastrointestinal diseases that are present in ASD include ulcerative colitis, inflammatory bowel disease, Crohn's disease, abdominal pain, constipation, diarrhea, gastroesophageal reflux, and nutritional disorders. These diseases are more common in children with ASD compared to neurotypical children. The severity of gastrointestinal malformations in ASD has been found to be associated with the severity of behavioral symptoms. Common symptoms of gastrointestinal disorders in ASD include hyperactivity, anxiety, aggression, self-mutilation, and changes in behavior. Gastrointestinal symptoms in ASD can be difficult to diagnose and may be misdiagnosed or not diagnosed at all. The presence of gastrointestinal disorders in ASD is associated with intellectual disability, sleep disorders, and the prescription of psychopharmacological treatment. Further research is needed to understand the specific phenotypic characteristics and biological markers underlying the association between gastrointestinal disorders and ASD.
What is the connection between gut and brain?5 answersThe gut and brain are closely connected through the brain-gut axis, which involves the interaction between the central nervous system and the enteric nervous system. This bidirectional communication occurs through sensory and autonomic pathways, allowing the brain to influence the function of the gastrointestinal (GI) tract and vice versa. The gut microbiota also plays a crucial role in this connection, with the composition and function of the microbiome affecting both GI and brain health. Dysbiosis, or an imbalance in the gut microbiome, has been linked to various diseases, including neurological disorders. Understanding the gut-brain connection has important implications for the treatment of functional GI disorders and neurological diseases.
What are Neurological Diseases with Gastrointestinal Effects?4 answersNeurological diseases can have gastrointestinal effects. Gastrointestinal disorders can be associated with neurological disease through various mechanisms such as nutritional deficiencies, immune-mediated processes, or degenerative changes. Common gastrointestinal symptoms in neurologic disorders include sialorrhea, dysphagia, gastroparesis, intestinal pseudo-obstruction, constipation, diarrhea, and fecal incontinence. Lesions in different brain structures can cause appetite loss, decreased peristalsis, decreased abdominal strain, hiccupping, and vomiting. Inflammatory diseases of the central and peripheral nervous system can also contribute to gastrointestinal dysfunction. Parkinson's disease, for example, is characterized by abnormal accumulation of α-synuclein fibrils and is often preceded by constipation. The gut microbiota may play a role in both intestinal and brain pathologies, and interventions targeting the gut microbiota and its metabolites may have potential therapeutic benefits for neurologic and gastrointestinal diseases.
What is the relationship between epilepsy and psychiatric disorders?5 answersEpilepsy is frequently associated with psychiatric disorders, including depression, anxiety, psychosis, and attention deficit/hyperactivity disorder (ADHD). The prevalence of psychiatric comorbidities in epilepsy patients varies depending on the type of epilepsy, with rates up to 51% in idiopathic generalized epilepsy (IGE), up to 43.1% in temporal lobe epilepsy (TLE), and up to 43.3% in a general population of epilepsy patients. Specific psychiatric disorders commonly observed in epilepsy patients include mood/affective disorders, anxiety disorders, personality disorders, and psychotic disorders. Patients with drug-resistant epilepsy have an increased polygenic burden for psychiatric disorders, particularly psychosis and depression, compared to responsive cases. Childhood maltreatment experiences are a powerful predictor for the occurrence of psychiatric comorbidities in epilepsy patients. The relationship between epilepsy and psychiatric disorders in adults with intellectual disabilities is less clear, with some studies showing no significant difference in the overall rate of psychiatric disorders between epilepsy and non-epilepsy groups.
Gut brain axis and neurological disorders?5 answersThe gut-brain axis is a communication system between the gut and the brain that plays a significant role in neurological disorders. Imbalances in the gut microbiome can contribute to the development and progression of these disorders. The gut microbiome affects the brain through the microbiota-gut-brain axis, which has been found to influence the pathophysiology of neurological disorders such as epilepsy, Parkinson's disease, and migraine. The gut microbiota regulates neurodevelopment through immune, neuronal, and endocrine/systemic pathways, and dysregulation of this axis has been implicated in neurodevelopmental disorders like autism spectrum disorder and attention deficit hyperactivity disorder. The gut microbiota also produces and modulates neurotransmitters, and its bidirectional communication with the brain has been linked to various neurological disorders including schizophrenia, depression, and anxiety. Furthermore, dysbiosis of the gut microbial makeup has been associated with the emergence of neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis.
Gut microbiome and mental health disorders?1 answersThe gut microbiome has been found to have an impact on mental health disorders such as depression, anxiety, autism, and schizophrenia. The gut and brain have a bidirectional communication known as the gut microbiome-brain axis, where disturbances in the gut microbiota can lead to dysregulation of pathways and trigger changes in the blood-brain barrier permeability, causing neurological and functional gastrointestinal disorders. Changes in the gut microbiome can result from factors such as diet, antibiotics, stress, and current illnesses. Genetic variants also play a role in shaping the gut microbiome and its connection to behavioral outcomes. Understanding the role of the gut microbiome can provide new tools for preventing, treating, or reducing symptoms of mental illness and improving general immune function. Probiotics and postbiotics may also have a beneficial role when used in conjunction with psychiatric medication.

See what other people are reading

Whats the impact of family issues as a contextual factor on outcomes for those with first episode psychosis?
5 answers
Family issues play a crucial role in the outcomes of individuals experiencing first-episode psychosis (FEP). Research indicates that high familial load for schizophrenia, environmental risk factors, and polygenic risk factors contribute to poor long-term functional outcomes in FEP patients. Additionally, family engagement has been shown to significantly impact patient disengagement from early intervention services, with higher family contact correlating with lower patient disengagement rates. Moreover, family environments characterized by emotional over-involvement and the presence of major depressive episodes within the family are predictors of psychotic relapses in FEP patients, emphasizing the importance of addressing family dynamics and depression in the care of individuals with FEP. Understanding and addressing family issues are essential for improving the prognosis and overall well-being of individuals with first-episode psychosis.
What are some of the key insights or arguments presented by Brandstetter?
5 answers
Brandstätter et al. presented insights regarding decision-making processes, particularly in risky choices. They compared various models, including the priority heuristic, expected value (EV) rule, and cumulative prospect theory (CPT), to explain how individuals make decisions between gambles. Brandstätter et al. argued that the EV rule combined with the priority heuristic did not fit as well as the CPT or the transfer of attention exchange (TAX) model in predicting choices. They highlighted the limitations of using an "as-if" model like the EV rule and emphasized the need to consider additional heuristics when explaining decision-making behavior. Brandstätter et al. also suggested that failures of the EV plus priority heuristic model should be seen as evidence for the existence of other decision-making heuristics.
Why Is Body dysmorphia under recognised?
5 answers
Body dysmorphia is under-recognized due to various factors. Research on body dysmorphic disorder (BDD) in men is limited, leading to a lack of awareness and understanding of the condition. The medical model of muscle dysmorphia (MD) has dominated, overlooking sociocultural factors that play a significant role in its development and maintenance. In military populations, despite the prevalence of BDD and MD, there is a lack of specific treatment studies, possibly due to a focus on physical appearance and fitness in the military environment. Additionally, the complexity of diagnosing BDD, often camouflaged by other psychiatric conditions, contributes to its under-recognition in clinical settings. The intersection of BDD symptomology and the experiences of sexual minority men remains understudied, further hindering recognition and understanding of the disorder.
How symptom burden related to quality of life for psychiatry?
4 answers
Symptom burden in psychiatric disorders is intricately linked to the quality of life (QoL) of patients and their caregivers. Studies have shown that patients with psychiatric disorders experience poorer QoL compared to healthy controls, emphasizing the impact of symptoms on overall well-being. Furthermore, caregivers of patients with psychiatric disorders, such as schizophrenia and chronic depression, experience a significant negative correlation between caregiver burden and QoL, indicating that as burden increases, QoL decreases. In the case of major neurocognitive disorder (mNCD), neuropsychiatric symptoms (NPSs) have been found to strongly correlate with QoL and caregiver burden, with NPSs having a twice stronger impact on caregiver burden than cognitive decline. Therefore, addressing symptom burden in psychiatric disorders is crucial for improving the QoL of both patients and their caregivers.
What is the definition of cognitive impairment in relation to academics?
4 answers
Cognitive impairment in relation to academics refers to deficits in cognitive abilities that impact a student's learning and educational performance. This impairment can manifest as difficulties in information processing speed, working memory, number sense, and fluid intelligence. Research suggests that cognitive abilities play a crucial role in academic achievement, with a positive association between academic success and cognitive ability. Cognitive dysfunction is a recognized feature of mood disorders like major depressive disorder and bipolar disorder, which can affect academic outcomes and functional performance. Furthermore, depression associated with cognitive impairment can lead to challenges in attention, concentration, and critical thinking, hindering academic progress and potentially causing a decline in academic performance. Understanding and addressing cognitive impairment are essential for optimizing educational outcomes and supporting students in their academic journey.
How does gadolinium retention differ between healthy individuals and those with neurological disorders, such as Alzheimer's disease?
5 answers
Gadolinium retention differs between healthy individuals and those with neurological disorders like Alzheimer's disease. In healthy individuals, gadolinium-based contrast agents (GBCAs) can lead to gadolinium retention in various tissues, including the brain, liver, skin, and bone. Studies have shown that gadolinium can be deposited in the brain, particularly in deep gray matter regions, even in patients without renal impairment. However, in patients with multiple sclerosis (MS), gadolinium retention in the brain, specifically in the dentate nuclei, does not seem to impact long-term motor or cognitive outcomes. Furthermore, in an experimental autoimmune encephalomyelitis (EAE) model, neuroinflammation was found to enhance gadolinium retention in the brain, with differences observed between macrocyclic and linear GBCAs in terms of retention profiles and potential neurotoxicity.
What are the sypmtoms of body dysmorphia?
5 answers
Body dysmorphic disorder (BDD) manifests with symptoms such as excessive preoccupation with imagined physical defects, leading to significant distress and impairment in daily functioning. Patients with BDD often experience severe anxiety, embarrassment, and avoidance of social situations. The disorder commonly begins in adolescence, progressing over time to meet diagnostic criteria, often accompanied by comorbid conditions like major depressive disorder, obsessive-compulsive disorder, and social anxiety disorder. Individuals with BDD may seek cosmetic treatments excessively, worsening their mental state. Symptoms include a persistent concern about perceived flaws, leading to repetitive behaviors and functional impairment. The diagnosis of BDD is challenging due to its chronic nature and the tendency of patients to seek cosmetic interventions rather than psychiatric help.
How are IPSC studies used to determine the neurodevelopmental role of loci implicated in Schizophrenia, such as CACNA1D?
5 answers
IPSC studies play a crucial role in investigating the neurodevelopmental implications of loci associated with schizophrenia, such as CACNA1D. These studies utilize induced pluripotent stem cells to model the disease, allowing for the examination of neurodevelopmental processes affected by genetic vulnerabilities. By analyzing gene expression patterns and functional changes in astrocytes and neurons derived from IPSCs of schizophrenia patients, researchers have identified alterations in calcium signaling, glutamate uptake, and metalloproteinase activity, implicating these processes in the pathology of schizophrenia. Additionally, IPSC studies have revealed deficiencies in neural connectivity, neurite outgrowth, and the misexpression of genes like NRG1, ZNF804A, and TCF4, shedding light on the developmental abnormalities associated with schizophrenia.
How the immune system might be involved in depression, including cytokine effects on neurons and neurotransmitters?
5 answers
The immune system plays a crucial role in depression, with evidence pointing towards immune activation contributing to the pathogenesis of the disorder. Studies have shown that immune activation, characterized by increased pro-inflammatory cytokines, is associated with depression. In particular, cytokines like interleukin-1β, interleukin-6, and tumor necrosis factor-α have been implicated in depression, affecting neuronal function and neurotransmitter activity. Additionally, alterations in T cell subtypes, especially Th17 cells producing interleukin-17A, have been linked to depression, influencing the gut-brain axis and stress responses. These findings suggest that immune-mediated mechanisms, including cytokine effects on neurons and neurotransmitters, play a significant role in the pathophysiology of depression, opening avenues for immune-modulating treatments in depression therapy.
How does in silico exploration aid in the discovery of potential anti-Parkinson effects for Punica Granatum?
5 answers
In silico exploration plays a crucial role in identifying potential anti-Parkinson effects for Punica Granatum by leveraging computational tools to predict interactions between bioactive compounds and target proteins. Studies have shown that Punica Granatum, rich in polyphenols like ellagitannins, exhibits neuroprotective properties through antioxidant, anti-inflammatory, and mitochondrial regulatory mechanisms. Computational analyses aid in understanding how these compounds interact with neuronal and glial cells, influence blood-brain barrier function, and restore redox balance in the brain. By simulating molecular interactions, in silico approaches provide insights into the mechanisms through which Punica Granatum polyphenols may mitigate Parkinson's disease symptoms, offering a promising avenue for the development of novel anti-Parkinson agents.
What is the role of genes coding dopamine receptors in depression?
7 answers
The role of genes coding for dopamine receptors in depression is multifaceted and complex, involving both direct and indirect pathways that influence depressive symptomatology. Research indicates that sequence variations in genes regulating dopamine neurotransmission, including those coding for dopamine receptors, may significantly influence depressive symptoms. For instance, a study found that a genetic risk score combining functional polymorphisms from dopamine receptor genes (DRD1, DRD2, DRD3) was associated with depressive symptomatology, suggesting that lower dopaminergic neurotransmission predicts higher levels of depression. This is further supported by findings that functional variants of the dopamine D4 receptor (DRD4) gene might be associated with depressive symptomatology, particularly delusional symptoms in mood disorders. Moreover, the role of dopamine receptors extends to their distribution in various brain regions and their involvement in neuroinflammatory processes that contribute to depression. The dopamine D3 receptor (D3R), for example, has been shown to influence depressive-like behaviors, neuroinflammation, and alterations in brain-derived neurotrophic factor (BDNF) levels in mesolimbic dopaminergic regions. Additionally, alterations in D3R expression and function have been correlated with depression severity, with evidence suggesting that D3R modulation can influence proinflammatory cytokines and the ERK1/2-cAMP-response element-binding protein (CREB) signaling pathway, which are critical in the pathophysiology of depression. The interaction between genetic predisposition and environmental factors also plays a crucial role in the etiology of depression. Studies highlight the importance of gene-gene-environment interactions, demonstrating that individuals with specific genotypes of COMT and DAT1 genes, which are involved in dopamine metabolism, are more sensitive to environmental factors like peer acceptance, which in turn affects depressive symptoms. In summary, genes coding for dopamine receptors play a critical role in depression through their influence on dopaminergic neurotransmission, interaction with environmental factors, and involvement in neuroinflammatory processes. These findings underscore the complexity of the genetic underpinnings of depression and highlight the potential for targeted therapeutic interventions.